Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements

Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements

Thumbnail Image
Download
Name

41467_2017_Article_353.pdf

Size

3.33 MB

Format

Adobe PDF

Checksum (MD5)

fdde464c948bcb28aa34f25cb09f93e6

Download all files submitted through automated deposit
sword-2017-11-13.original.zip (2.79 MB)
Author(s)
Dunn, Denise E.
•
Avila-Pacheco, Julian
•
Greengard, Paul
•
Clish, Clary B.
•
Lo, Donald C.
•
Pirhaji, Leila
•
Milani, Pamela
•
Dalin, Simona
•
Wassie, Brook T.
•
Fenster, Robert
more
Date Issued
September 2017
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Pirhaji, Leila et al “Identifying Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements.” Nature Communications 8, 1 (September 2017): 623 © 2017 The Author(s)
Version
Final published version
Abstract
The immense and growing repositories of transcriptional data may contain critical insights for developing new therapies. Current approaches to mining these data largely rely on binary classifications of disease vs. control, and are not able to incorporate measures of disease severity. We report an analytical approach to integrate ordinal clinical information with transcriptomics. We apply this method to public data for a large cohort of Huntington's disease patients and controls, identifying and prioritizing phenotype-associated genes. We verify the role of a high-ranked gene in dysregulation of sphingolipid metabolism in the disease and demonstrate that inhibiting the enzyme, sphingosine-1-phosphate lyase 1 (SPL), has neuroprotective effects in Huntington's disease models. Finally, we show that one consequence of inhibiting SPL is intracellular inhibition of histone deacetylases, thus linking our observations in sphingolipid metabolism to a well-characterized Huntington's disease pathway. Our approach is easily applied to any data with ordinal clinical measurements, and may deepen our understanding of disease processes.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Picower Institute for Learning and Memory
Terms of Use
Creative Commons Attribution 4.0 International License
http://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/112189
DOI of Published Version
https://doi.org/10.1038/s41467-017-00353-6
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.